H. R. Koene, M. Kleijer, J. Algra, D. Roos, A. E. Dem-borne et al., Fcí µí»¾RIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fcí µí»¾RIIIa, independently of the Fcí µí»¾RIIIa, Blood, vol.90, issue.3, pp.1109-1114, 1997.

G. Cartron, L. Dacheux, and G. Salles, Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fcgamma RIIIa gene, Blood, vol.99, issue.3, pp.754-758, 2002.
DOI : 10.1182/blood.V99.3.754

B. Clémenceau, N. Congy-jolivet, and G. Gallot, Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes, Blood, vol.107, issue.12, pp.4669-4677, 2006.
DOI : 10.1182/blood-2005-09-3775

B. Clémenceau, G. Gallot, R. Vivien, J. Gaschet, M. Campone et al., Long-Term Preservation of Antibody-Dependent Cellular Cytotoxicity (ADCC) of Natural Killer Cells Amplified In Vitro From the Peripheral Blood of Breast Cancer Patients After Chemotherapy, Journal of Immunotherapy, vol.29, issue.1, pp.53-60, 2006.
DOI : 10.1097/01.cji.0000175686.13368.5c

C. H. June, B. R. Blazar, and J. L. Riley, Engineering lymphocyte subsets: tools, trials and tribulations, Nature Reviews Immunology, vol.112, issue.10, pp.704-716, 2009.
DOI : 10.1038/nri2635
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412112

G. Gross, T. Waks, and Z. Eshhar, Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity., Proceedings of the National Academy of Sciences, vol.86, issue.24, pp.10024-10028, 1989.
DOI : 10.1073/pnas.86.24.10024

Z. Eshhar, T. Waks, G. Gross, and D. G. Schindler, Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors., Proceedings of the National Academy of Sciences, vol.90, issue.2, pp.720-724, 1993.
DOI : 10.1073/pnas.90.2.720

Z. Eshhar, T. Waks, and G. Gross, The Emergence of T-Bodies/CAR T Cells, The Cancer Journal, vol.20, issue.2, pp.123-126, 2014.
DOI : 10.1097/PPO.0000000000000027

S. Gill and C. H. June, Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies, Immunological Reviews, vol.99, issue.20 Pt 1, pp.68-89, 2015.
DOI : 10.1111/imr.12243

R. A. Morgan, J. C. Yang, M. Kitano, M. E. Dudley, C. M. Laurencot et al., Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2, Molecular Therapy, vol.18, issue.4, pp.843-851, 2010.
DOI : 10.1038/mt.2010.24

L. Boissel, M. Betancur, and W. Lu, Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity, OncoImmunology, vol.9, issue.10, 2014.
DOI : 10.4161/onci.26527

D. V. Tassev, M. Cheng, and N. Cheung, Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor, Cancer Gene Therapy, vol.177, issue.2, pp.84-100, 2012.
DOI : 10.1182/blood-2003-05-1433

S. Uchiyama, Y. Suzuki, and K. Otake, Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope, Cancer Science, vol.103, issue.1, pp.201-209, 2010.
DOI : 10.1111/j.1349-7006.2009.01392.x

K. Schönfeld, C. Sahm, and C. Zhang, Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor, Molecular Therapy, vol.23, issue.2, pp.330-338, 2015.
DOI : 10.1038/mt.2014.219

O. H. Brekke, T. E. Michaelsen, and I. Sandlie, The structural requirements for complement activation by IgG: does it hinge on the hinge?, Immunology Today, vol.16, issue.2, pp.85-90, 1995.
DOI : 10.1016/0167-5699(95)80094-8

S. Wilkie, G. Picco, and J. Foster, Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor, The Journal of Immunology, vol.180, issue.7, pp.4901-4909, 2008.
DOI : 10.4049/jimmunol.180.7.4901

R. D. Guest, R. E. Hawkins, and N. Kirillova, The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors, Journal of Immunotherapy, vol.28, issue.3, pp.203-211, 2005.
DOI : 10.1097/01.cji.0000161397.96582.59

B. Savoldo, C. A. Ramos, and E. Liu, CD28 costimulation improves expansion and persistence of chimeric antigen receptor???modified T cells in lymphoma patients, Journal of Clinical Investigation, vol.121, issue.5, pp.1822-1826, 2011.
DOI : 10.1172/JCI46110DS1

A. Hombach, A. A. Hombach, and H. Abken, Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc ???spacer??? domain in the extracellular moiety of chimeric antigen receptors avoids ???off-target??? activation and unintended initiation of an innate immune response, Gene Therapy, vol.147, issue.10, pp.1206-1213, 2010.
DOI : 10.1038/sj.gt.3301051

B. G. Till, M. C. Jensen, and J. Wang, CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results, Blood, vol.119, issue.17, pp.3940-3950, 2012.
DOI : 10.1182/blood-2011-10-387969

M. Casucci, B. N. Di-robilant, and L. Falcone, CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma, Blood, vol.122, issue.20, pp.3461-3472, 2013.
DOI : 10.1182/blood-2013-04-493361

M. Hudecek, D. Sommermeyer, and P. L. Kosasih, The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity, Cancer Immunology Research, vol.3, issue.2, pp.125-135, 2015.
DOI : 10.1158/2326-6066.CIR-14-0127

P. Bruhns, B. Iannascoli, and P. England, Specificity and affinity of human Fc?? receptors and their polymorphic variants for human IgG subclasses, Blood, vol.113, issue.16, pp.3716-3725, 2009.
DOI : 10.1182/blood-2008-09-179754
URL : https://hal.archives-ouvertes.fr/pasteur-00363931

P. Bruhns, Properties of mouse and human IgG receptors and their contribution to disease models, Blood, vol.119, issue.24, pp.5640-5649, 2012.
DOI : 10.1182/blood-2012-01-380121

M. B. Overdijk, S. Verploegen, and A. Ortiz-buijsse, Crosstalk between Human IgG Isotypes and Murine Effector Cells, The Journal of Immunology, vol.189, issue.7, pp.3430-3438, 2012.
DOI : 10.4049/jimmunol.1200356

S. Swift, J. Lorens, P. Achacoso, and G. P. Nolan, UNIT 1017C Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems, Current Protocols inhindawi.com Stem Cells International, 2001.